Dermaviska Advanced Technologies

Introduction

Welcome to the Dermaviska Technology Overview. At Dermaviska, owned and operated by Truviska Pharmaceutical Private Limited, every formulation is engineered using advanced pharmaceutical skin delivery systems.

Topical skincare efficacy relies heavily on how effectively active ingredients penetrate the stratum corneum barrier without triggering irritation or damaging natural ceramide structures. Dermaviska delivery systems utilize biomimetic lipid carriers and micro-encapsulation to ensure optimal stability, targeted transdermal transport, and long-lasting therapeutic performance for skin and scalp care.

Why Dermaviska Technology

Traditional topical solutions often face significant physical and chemical limitations:

• Poor Barrier Penetration: Actives remain trapped on the skin surface, creating waxy or greasy residues instead of reaching target dermal layers.
• Drying Solvent Irritation: High concentrations of volatile alcohols and glycols are frequently used as cheap permeation enhancers, causing transepidermal water loss (TEWL), redness, and burning.
• Active Degradation & Odors: Sensitive compounds (such as Ketoconazole, Salicylic Acid, or Selenium Disulphide) break down quickly upon air or light exposure, generating harsh chemical odors.

Dermaviska overcomes these challenges through novel delivery platforms that shield active molecules, match natural skin lipid structures, and release potent ingredients steadily over 12 hours.

Tripomer Technology

What is Tripomer Technology?

TRIPOMER is a fast-acting, patented dermal delivery platform engineered with a novel and stable mixture of cetylated esters, acrylic acid polymers, cetyl/stearyl alcohols, antioxidants, and polar/non-polar solvents. The resulting particles possess micelle and colloid properties, differentiating them from conventional liposomes, niosomes, or polymeric micelles.

How It Works

• Biomimetic Lipid Matching: Structural similarity between ceramides in human epidermal lipids and cetylated esters in TRIPOMER allows particles to navigate stratum corneum lipid bilayers easily.
• Reversible Permeability Adjustment: Upon application, the vehicle fluid diffuses into the stratum corneum, allowing micellar complexes to concentrate actives and temporarily organize lipid packing without permanently damaging barrier function.
• Transfollicular Transport: On the scalp, structural affinity with sebum triglycerides enables key molecules to dissolve in scalp sebum, penetrating outer root sheath cell barriers to reach the dermal papilla.

Clinical Benefits & Franz Cell IVRT Proof

Comparative Vertical Franz Diffusion Cell studies ($n = 6$, $32^\circ\text{C}$ skin-simulated conditions) evaluated cumulative 12-hour active release:

• Sample B (TRIPOMER System): 118.7 $\mu\text{g/cm}^2$ cumulative release ($p < 0.05$).
• Sample C (High-Glycol Vehicle): 82.0 $\mu\text{g/cm}^2$ cumulative release.
• Sample A (Traditional Alcohol Base): 76.4 $\mu\text{g/cm}^2$ cumulative release.

All TRIPOMER formulations follow Higuchi release kinetics, guaranteeing controlled diffusion without waxy residues or skin irritation.

Active Microbeads Technology

What is Active Microbeads Technology?

Active Microbeads Technology is a micro-encapsulation system developed for scalp and skin cleansing therapies containing sensitive therapeutic agents such as Selenium Disulphide, Ketoconazole, and Salicylic Acid.

How It Works

• Encapsulated Stability: Delicate active compounds are sealed within protective micro-spheres, shielding them from air, light, and premature degradation.
• Friction-Controlled Dissolve: Microbeads dissolve cleanly during gentle massage, releasing fresh, undegraded active ingredients uniformly across affected skin or scalp areas.
• Keratolytic Scale Clearance: Loosens attachments between corneocytes, dissolving adherent dandruff scales and washing away excess fungi (*Malassezia furfur*, dermatophytes) and sebum.

Core Benefits

• Eliminates unpleasant sulphur chemical odors associated with traditional Selenium Disulphide washes.
• Maintains scalp and skin friendly pH (5.5) without stripping natural oils.
• Prevents active degradation, ensuring 100% therapeutic potency per application.

Technology Comparison

A structural comparison between traditional topical products and Dermaviska advanced delivery platforms:

Why It Matters For Your Skin

Effective skincare is not just about high active concentration—it is about precision active delivery. By combining micellar polymeric carriers with micro-encapsulated active stability, Dermaviska delivers measurable clinical advantages:

• Enhanced Bioavailability: Active ingredients reach deeper epidermal layers where cellular repair occurs.
• Reduced Transepidermal Water Loss: Lipophilic ester matching strengthens stratum corneum hydration.
• Superior User Compliance: Pleasant, non-irritating, and odorless formulations ensure consistent long-term use.

Frequently Asked Questions

Scientific Disclaimer

The information on this page is provided for educational and informational purposes regarding Dermaviska proprietary delivery technologies. While our formulations undergo rigorous IVRT and laboratory evaluations, individual results may vary based on skin type and condition. Dermaviska products are not intended to diagnose, treat, cure, or prevent any medical condition unless prescribed by a licensed healthcare professional.

Contact Us

For scientific inquiries, product information, or medical partnerships, please contact: